vaccine production

... RNA, or for vaccine purposes. We have also developed an innovative and patented technology (Staby®) for the antibiotic-free bioproduction of plasmids and recombinant proteins in E. coli cells. Our technology significantly increases the stability of plasmid DNA in host strains, resulting in an overall improvement in production yield and reproducibility. It serves as a good alternative to standard antibiotic resistance genes and meets regulatory demands. Please feel free to contact us for more information!

CRO in biotechnology, LPS-BioSciences specializes in bacterial endotoxins. LPS-BioSciences provides services, products, and research to help companies in human and animal health manage endotoxin issues. Our areas of application include the vaccine industry, in vitro diagnostics, cosmetics, and medical devices. Our expertise encompasses the production and custom extraction of lipopolysaccharides...